NEUBASE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4336 USD | +3.26% |
|
+5.73% | -41.41% |
| Mar. 26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
| Mar. 26 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
Chart calendar NeuBase Therapeutics, Inc.
8dd5278d9e904a2.7oXBVmemQPrvpy18I0AckpWBo19zwGUn5M7i0Laq9jU.w7P2FSTUDMuOlmEScRNQ-_P552xLhC1enJaL6Pj_omO9z_McX-I1w8L9Xg~b950c6af5ed7e54331ee3e80a987ec02
Upcoming events on NeuBase Therapeutics, Inc.
No events available
Past events on NeuBase Therapeutics, Inc.
| 2023-09-28 08:30 am | Annual General Meeting |
| 2023-06-23 | American Peptide Symposium |
| 2023-06-14 | Reverse Split: 1 of 20 |
| 2023-06-09 08:00 am | Jefferies Global Healthcare Conference |
| 2023-05-20 11:30 am | American Society of Gene Cell Therapy Meeting - Abstract No 335 |
| 2023-05-18 04:45 pm | American Society of Gene Cell Therapy Meeting - Abstract No 131 |
| 2023-02-14 04:10 pm | Q1 2023 Earnings Release |
| 2022-12-21 08:00 am | FY 2022 Earnings Release |
| 2022-10-03 09:00 am | Chardan Genetic Medicines Conference |
| 2022-09-08 08:30 am | Annual General Meeting |
| 2022-08-11 08:00 am | Q3 2022 Earnings Release |
| 2022-06-10 09:00 am | Jefferies Healthcare Conference |
| 2022-05-18 05:30 pm | American Society of Gene and Cell Therapy Conference - Abstract Number: 1049 |
| 2022-05-17 05:30 pm | American Society of Gene and Cell Therapy Conference - Abstract Number: 585 |
| 2022-05-12 05:00 pm | Interim 2022 Earnings Release |
| 2022-03-16 02:40 pm | Oppenheimer Healthcare Conference - Fireside Chat |
| 2022-03-16 10:30 am | MDA Clinical & Scientific Conference |
| 2022-03-12 | MDA Clinical & Scientific Conference - Pharmacology, Biodistribution and Tolerability |
| 2022-02-10 | Q1 2022 Earnings Release |
| 2022-02-10 | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -26,3 -5,63 -367.84% | -17,1 -16,8 -1.82% | -26,6 -27,0 1.59% | -33,3 -34,3 3% | -14,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,0 -5,61 -380.84% | -17,4 -17,3 -0.3% | -25,4 -26,0 2.34% | -33,8 -34,8 2.97% | -12,3 |
|
Net income Million USD | Released Forecast Spread | -27,0 -5,61 -380.84% | -17,4 -17,3 -0.3% | -25,4 -26,0 2.34% | -33,8 -34,8 2.97% | -12,3 |
|
EPS USD | Released Forecast Spread | -65,2 -25,5 -155.35% | -17,8 -17,8 0% | -18,6 -19,0 2.11% | -20,8 -21,6 3.7% | -7,29 |
| Announcement Date | 09/01/20 | 23/12/20 | 23/12/21 | 21/12/22 | - |
Quarterly results
| Fiscal Period | September | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -8,84 -6,30 -40.3% | -7,17 -7,60 5.64% | -7,30 -7,73 5.46% | -9,93 -7,71 -28.82% | -8,36 -9,60 12.91% | -7,72 -8,75 11.76% | -4,16 -3,20 -30.13% | -3,69 -3,15 -17.08% | -2,81 -3,00 6.37% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,66 -6,74 -28.45% | -7,16 -7,78 8.04% | -7,73 -7,87 1.83% | -9,92 -7,82 -26.95% | -8,49 -9,59 11.48% | -7,63 -8,67 11.94% | -4,37 -3,51 -24.39% | -4,09 -3,21 -27.41% | -3,45 -3,11 -10.83% | -1,82 -1,67 -9.28% |
|
Net income Million USD | Released Forecast Spread | -8,66 -6,74 -28.45% | -7,16 -7,78 8.04% | -7,73 -7,87 1.83% | -9,92 -7,82 -26.95% | -8,49 -9,59 11.48% | -7,63 -8,67 11.94% | -4,37 -3,51 -24.39% | -4,09 -3,21 -27.41% | -3,45 -3,11 -10.83% | -1,82 -1,67 -9.28% |
|
EPS USD | Released Forecast Spread | -5,80 -4,40 -31.82% | -4,20 -4,73 11.27% | -4,80 -4,90 2.04% | -6,00 -4,80 -25% | -5,20 -5,93 12.36% | -4,80 -5,53 13.25% | -2,60 -2,20 -18.18% | -2,40 -2,00 -20% | -2,04 -2,10 2.86% | -0,66 -0,97 31.96% |
| Announcement Date | 13/08/21 | 23/12/21 | 11/02/22 | 12/05/22 | 11/08/22 | 21/12/22 | 14/02/23 | 11/05/23 | 14/08/23 | 09/11/23 |
More events
Past sector events for NeuBase Therapeutics, Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NBSE Stock
- Calendar NeuBase Therapeutics, Inc.
